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Impact of Stress Hormones and IUGR Fetal Conditions 
on Myoblast Function
Hannah Riley, Kristin Beede, and Dustin Yates
Department of Animal Science, University of Nebraska-Lincoln
Abstract
Chronic fetal stress causes adaptive responses that result in intrauterine growth restriction (IUGR). Maternal stressors
including heat stress, illness, and obesity cause placental dysfunction that harshens the intrauterine environment by
inducing hypoxia and nutrient restriction. IUGR fetuses have restricted growth through the last trimester and after birth.
The objective of this study was to test the effects of stress hormones on myoblast proliferation rates. L6 cells and
primary myoblasts that were isolated from IUGR fetal sheep in a previous study were used to study the effects of stress
hormones on myoblast proliferation and myoblast gene expression. Incubation in epinephrine-spiked media initially
reduced L6 cell proliferation at 4 hours but then increased proliferation at 48 and 96 hours. TNFa, IL-6 and TWEAK all
increased proliferation rates, but the quickest and most profound increase was with IL-6. Although IUGR fetal myoblasts
showed greater proliferation rates than controls, proliferation rates didn’t change with increasing amounts of
norepinephrine or insulin in controls or IUGR myoblasts. Together our findings show that increased exposure to stress
hormones have a positive effect on myoblast proliferation, especially in relatively short durations (48-96 hours).
Introduction
Research has shown that skeletal muscle is the major tissue involved in adaptive fetal growth restriction. IUGR fetuses
diagnosed by ultrasound have less muscle in late gestation and offspring have slower muscle growth and acrue fat
faster during childhood. Late gestation and after birth, skeletal muscle growth relies on myoblast proliferation and
incorporation into existing fibers instead of increasing fiber numbers. Recent studies have shown stress hormones may
regulate myoblast function even at sub acute levels. By using an in vitro and ex vivo system, we were able to investigate
the effects of hypercatecholaminemia and inflammatory actions on skeletal muscle proliferation. We hypothesize that L6
extended culture with stress hormones will affect proliferation rates.
Summary
48 to 96-hour exposure to pro-inflammatory cytokines and epinephrine has a positive effect on myoblast proliferation and
may explain greater proliferation in IUGR fetal myoblasts, as IUGR fetuses are known to be hypercatecholaminemic.
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Materials and Methods
L6 Myoblast Proliferation
1.) L6 myoblasts were plated in 6-well fibronectin-coated plates at a density that yielded ~60k cells at collection.
2.) Myoblasts were grown in common growth media spiked with the following treatments (n=8) for either 4, 48, or 96 hrs:
Control: no additive, Insulin: 1 mU/ml, Epinephrine: 10 nM, IL-6: 1 ng/ml, TNFa: 20 ng/ml, TWEAK: 10 ng/ml
3.) Proliferation rates were determined by EdU pulse for the final 2 hours of the incubation period.
4.) Myoblasts were lifted off the plate and then fixed using 4% PFA. Cells were washed, permeabilized, and stained using
a Click-iT Alexa Fluor 555 kit (Thermo Scientific).
5.) Cells were suspended in Moxi Cyte Reagent (Orflo) and analyzed using a zEPI Flow Cytometer (Orflo) for percent
positive staining for EdU as a measure of proliferation rate.
L6 Myoblast Gene Expression
1.) RNA was extracted from 96 hrs cultured myoblasts that we treated the same as the L6 proliferation study using a
RNeasy Mini Kit (Qiagen) and was reverse transcribed to cDNA using QuantiTect Reverse Transcription Kit (Qiagen).
2.) Validated oligonucleotide primers for TWEAK receptor (Fn14), TNF receptor 1 (TNFR1), IL-6 receptor (IL6R),
adrenergic receptor β2 (ADRβ2), and the housekeeping gene Ywhaz (Bio-Rad) were measured by droplet digital PCR.
3.) Droplets were generated from a 20-µl reaction of EvaGreen supermix, primers, and cDNA template with 70µl of
droplet generation oil. The resulting droplets were transferred to a heat-sealed 96-well plate for thermal cycling under
manufacturer-recommended conditions.
4.) Number of copies were determined using a QX200 Droplet Digital PCR system (Bio-Rad Laboratories) and copy
number was determined with QuantaSoft 1.7.4. software (Bio-Rad Laboratories).
IUGR Fetal Myoblast Proliferation
1.) IUGR myoblasts cells were isolated from fetal semitendinosus muscle from ewes that were euthanized at 134 ± 1 day
of gestational age (dGA). These ewes had been exposed to elevated ambient temperatures (35-400C) from the 40th to
95th dGA. Control ewes were housed at 250C. After cells were isolated and purified, they were stored in liquid nitrogen
until the proliferation study was performed.
2.) For this study - cells were plated at a density of 4,000 cells per well in 6-well fibronectin-coated plates (n=2 per
treatment).
3.) Cells were grown in complete growth media for 4 days, with one media change on day 2.
4.) On the 4th day, cells were incubated in treatment media for 4 hours. For the first 2 hours cells were incubated in
treatment media only, but for the final 2 hours cells were incubated in treatment media + 10 µM EdU.
Treatments Medias: Media A: no additive, Media B: 50 pM Norepinephrine (NE), Media C: 500 pM NE, Media D: 5
mU/mL Insulin (Ins), Media E: 5 mU/mL Ins + 50 pM NE, Media F: 5 mU/mL Ins + 500 pM NE
5.) Following the 4 hour incubation period cells were accutased off the plate, fixed with 4% PFA and stained the same
way as steps 5-8 from the L6 myoblast proliferation protocol above.
• Epinephrine initially reduced and ultimately increased L6 myoblast proliferation
• Pro-inflammatory cytokines increased proliferation, with the quickest and most profound effect from IL-6
• IL-6 profoundly increased mRNA for all 3 cytokine receptors
• TNFa increased mRNA for all 3 cytokine receptors, but to a lesser
extent than IL-6
• Epinephrine increased TNFR1 mRNA expression only
• All treatments reduced mRNA expression of ADRβ2
• IUGR Fetal Myoblasts showed greater basal proliferation
than controls
• Proliferation rate didn’t change with increasing amounts
of Insulin or Norepinephrine
Results
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